Doctor and nurse discussing what they see on the clipboard as they are walking
HealthJanuary 30, 2020

Coronavirus Resources and Guidance for Clinicians

The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak of respiratory illness caused by a 2019 Novel (new) Coronavirus (2019-nCoV) which was first identified in Wuhan, Hubei Province, China.Early on, patients in Wuhan, China reportedly had some link to a large seafood and animal market, suggesting animal-to-person spread. However, a growing number of patients reportedly have not had exposure to animal markets, indicating person-to-person spread is occurring. Currently, it’s unclear how easily or sustainably this virus is spreading between people.

People around the world commonly get infected with human coronaviruses 229E, NL63, OC43, and HKU1. Coronaviruses that infect animals can evolve, make people sick and become a new human coronavirus. Examples of these include SARS-CoV, MERS-CoV, and now 2019-nCoV.

Novel Coronavirus resources from around the world are available on Wolters Kluwer’s UpToDate® web page Society Guideline Links: Novel Coronavirus

The latest U.S. situation summary updates are available on CDC’s web page 2019 Novel Coronavirus, Wuhan, China

The latest U.S. guidance for healthcare professionals is available on CDC’s web page Interim Guidance for Healthcare Professionals

Key Messages:

  1. Health care providers should obtain a detailed travel history for patients being evaluated with fever and acute respiratory illness.
  2. Patients in the United States who meet CDC patient under investigation (PUI) for 2019-nCoV criteria should be evaluated in association with the outbreak of 2019-nCoV in Wuhan City, China.
  3. Healthcare providers should immediately notify both infection control personnel at their healthcare facility and their local or state health department in the event of a PUI for 2019-nCoV.
  4. At this time, diagnostic testing for 2019-nCoV can be conducted only at CDC. Specific specimen/laboratory guidance is available on CDC’s web page Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from PUIs for 2019-nCoV

The latest U.S. guidance for Infection Prevention and Control is available on CDC’s web page Interim CDC Guidance for Infection Prevention and Control

This is an emerging, rapidly evolving situation and Healthcare Providers should refer to the CDC for the most updated information as it becomes available.


Trusted real-time alerts and evidence-based guidance to ensure at-risk patients receive the right care at the right time, every time.

Sentri7's sophisticated algorithms identify at-risk patients in real-time by breaking down data silos that exist across hospitals and driving consistent clinical action. All to improve patient outcomes and hospital performance.